ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 52 filers reported holding ALIGOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $81 | -91.9% | 85 | -84.9% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 563 | -65.1% | 0.00% | – |
| Q2 2022 | $2,000 | -86.7% | 1,612 | -76.8% | 0.00% | – |
| Q1 2022 | $15,000 | -83.1% | 6,949 | -7.6% | 0.00% | – |
| Q4 2021 | $89,000 | +85.4% | 7,519 | +140.8% | 0.00% | – |
| Q3 2021 | $48,000 | +11.6% | 3,122 | +49.7% | 0.00% | – |
| Q2 2021 | $43,000 | +59.3% | 2,085 | +73.2% | 0.00% | – |
| Q1 2021 | $27,000 | -48.1% | 1,204 | -36.5% | 0.00% | – |
| Q4 2020 | $52,000 | – | 1,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $1,733,325 | 0.92% |
| TANG CAPITAL MANAGEMENT LLC | 3,329,048 | $2,486,799 | 0.35% |
| Vivo Capital, LLC | 3,547,030 | $2,649,631 | 0.29% |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $555,182 | 0.22% |
| Newtyn Management, LLC | 920,000 | $687,240 | 0.17% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 631,887 | $472,020 | 0.14% |
| EcoR1 Capital, LLC | 3,948,360 | $2,949,425 | 0.10% |
| HHLR ADVISORS, LTD. | 2,309,764 | $1,725,394 | 0.04% |
| Baker Brothers Advisors | 2,076,400 | $1,551,071 | 0.01% |
| HARBOURVEST PARTNERS LLC | 18,783 | $14,031 | 0.01% |